This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peralta, J M Articles by Reed, S G Search for Related Content PubMed PubMed Citation Articles by Peralta, J M Articles by Reed, S G

 Previous Article  |  Next Article 

J Clin Microbiol. 1994 April; 32(4): 971-974

Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens.

Instituto de Microbiologia, UFRJ, Rio de Janerio, Brazil.

ABSTRACT

An enzyme-linked immunosorbent assay (ELISA) was developed for detecting antibodies against Trypanosoma cruzi. Two synthetic T. cruzi peptides, TcD and PEP2, were used. The specificity and sensitivity of the peptide ELISA were determined with 260 serum samples from individuals living in an area in which Chagas' disease is endemic. ELISAs were performed with the peptides singly or in combination. The evaluation of these tests showed that 168 (93.8%) of 179 serum samples from T. cruzi-infected patients were positive when TcD peptide was used as antigen; 164 (91.6%) samples were positive with PEP2, and 178 (99.4%) samples were positive when the two peptides were combined. Thus, the sensitivity of the ELISA using the two peptides exceeded 99%. The specificity was evaluated by using a panel of 118 serum samples that included samples from 81 individuals living in an area of endemicity with negative serology for Chagas' disease and from 37 patients from areas in which T. cruzi was not endemic but with other pathologies, such as leishmaniasis, tuberculosis, and leprosy. Only two false-positive serum samples were found in this group of individuals, giving a test specificity of more than 98%. Because these peptides can be synthesized and are very stable at room temperature, the use of such reagents can improve the standardization and reproducibility of ELISAs for the serodiagnosis of T. cruzi infection.

This article has been cited by other articles:

• Umezawa, E. S., Luquetti, A. O., Levitus, G., Ponce, C., Ponce, E., Henriquez, D., Revollo, S., Espinoza, B., Sousa, O., Khan, B., da Silveira, J. F. (2004). Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American Countries. J. Clin. Microbiol. 42: 449-452 [Abstract] [Full Text]  
• Ferreira, A. W., Belem, Z. R., Lemos, E. A., Reed, S. G., Campos-Neto, A. (2001). Enzyme-Linked Immunosorbent Assay for Serological Diagnosis of Chagas' Disease Employing a Trypanosoma cruzi Recombinant Antigen That Consists of Four Different Peptides. J. Clin. Microbiol. 39: 4390-4395 [Abstract] [Full Text]  
• Girones, N., Rodriguez, C. I., Basso, B., Bellon, J. M., Resino, S., Munoz-Fernandez, M. A., Gea, S., Moretti, E., Fresno, M. (2001). Antibodies to an Epitope from the Cha Human Autoantigen Are Markers of Chagas' Disease. CVI 8: 1039-1043 [Abstract] [Full Text]  
• Umezawa, E. S., Bastos, S. F., Camargo, M. E., Yamauchi, L. M., Santos, M. R., Gonzalez, A., Zingales, B., Levin, M. J., Sousa, O., Rangel-Aldao, R., da Silveira, J. F. (1999). Evaluation of Recombinant Antigens for Serodiagnosis of Chagas' Disease in South and Central America. J. Clin. Microbiol. 37: 1554-1560 [Abstract] [Full Text]  
• Oelemann, W. M. R., Teixeira, M. D. G. M., Veríssimo Da Costa, G. C., Borges-Pereira, J., De Castro, J. A. F., Coura, J. R., Peralta, J. M. (1998). Evaluation of Three Commercial Enzyme-Linked Immunosorbent Assays for Diagnosis of Chagas' Disease. J. Clin. Microbiol. 36: 2423-2427 [Abstract] [Full Text]